Compare IRON & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRON | PJT |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.9B |
| IPO Year | N/A | N/A |
| Metric | IRON | PJT |
|---|---|---|
| Price | $80.40 | $172.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 4 |
| Target Price | $108.85 | ★ $190.33 |
| AVG Volume (30 Days) | ★ 646.9K | 234.4K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | ★ 72.84 |
| EPS | N/A | ★ 6.53 |
| Revenue | N/A | ★ $1,657,789,000.00 |
| Revenue This Year | N/A | $15.24 |
| Revenue Next Year | N/A | $10.85 |
| P/E Ratio | ★ N/A | $26.37 |
| Revenue Growth | N/A | ★ 23.30 |
| 52 Week Low | $30.82 | $119.76 |
| 52 Week High | $99.50 | $190.28 |
| Indicator | IRON | PJT |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 52.64 |
| Support Level | $71.41 | $169.42 |
| Resistance Level | $92.00 | $173.68 |
| Average True Range (ATR) | 4.40 | 4.03 |
| MACD | -1.73 | 0.08 |
| Stochastic Oscillator | 31.96 | 33.85 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.